Walgreens Acquired by Sycamore Group in $23.7 Billion Transaction
Walgreens Boots Alliance Inc. (WBA) has entered into a definitive agreement to be acquired by private equity firm Sycamore Partners for up to $23.7 billion. The transaction includes $11.45 per share in cash and the right to receive up to $3.00 per share in additional proceeds from the monetization of WBA's VillageMD holding in the future.
Under the agreement, WBA will operate under its Walgreens and Boots brands and remain headquartered in the Chicago area.
WBA's popular pharmacy, beauty and personal care products will continue to be offered, supported by Sycamore's retail and consumer expertise.
If the transaction closes by the end of 2025, shareholders will benefit from a premium of nearly 63% to WBA's stock price. WBA leadership emphasized that privatization will help achieve strategic transformation and operational improvements more quickly, especially in the competitive retail healthcare market.
The privatization is intended to simplify WBA's transformation strategy in the evolving pharmacy and cosmetics sectors, making it more flexible and adaptable to consumer needs. By joining forces with Sycamore, which has extensive experience in retail transformation, WBA aims to strengthen its market position in the healthcare and beauty sectors with enhanced, consumer-centric offerings.
2026-09-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BioNTech’s Founders Turn the Page
-
Due to Supply Chain Disruptions, A Major MDI/TDI Facility in the Middle East has Suddenly Shut Down!
-
Henkel to Acquire Olaplex in $1.4 Billion Deal
-
LANXESS Raises Global 1,6-Hexanediol Prices by 20% as Cost Pressure Begins to Pass Downstream
-
BorsodChem Raises MDI Prices by €500 as Cost Pressure in Europe’s Polyurethane Chain Continues to Escalate
-
BASF Raises BA and 2-EHA Prices as Acrylic Ester Costs Continue to Move Higher in Asia-Pacific
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
Recommend Reading
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
Givaudan Breaks Ground on New Fragrance Factory in Guangzhou
-
Sinopec Builds 146 Hydrogen Refueling Stations, Ranking Among the World’s Largest Operators
-
Nylon Giant to Close Another European Plant, Cutting 140 Jobs
-
Türkiye Advances $3 Billion Petrochemical Cluster Targeting 17% of Domestic Polypropylene Demand
-
EFSA Reviews Clodinafop Risk
-
EFSA Reviews Clodinafop Risk
-
Premium Global Chemical Sourcing Requests (30 Mar-1Apr, 2026)
-
Favorable Factors Boost Shandong Cyclohexanone Market Prices by Over 30% in March
-
Cost Pulls Up March PC Market Performance